The Office of Minority Health announced phase one winners of The HIV Challenge, a national competition seeking innovative approaches to reduce HIV-related stigma and increase prevention and treatment among minority communities. The HIV Challenge provides an opportunity for individuals and organizations to develop novel, innovative approaches for implementat
Tennessee anti-drug coalitions are working to reduce dependence on harmful and potentially lethal substances such as prescription drugs, alcohol, and tobacco. In partnership with the Hamilton County Coalition, researchers from Vanderbilt University Medical Center (VUMC) collect and analyze program demographics and outcomes. The Nu-Start program provides access to treatment and recovery services for individuals and families overcoming opioid dependency.
The project connects Vanderbilt researchers across disciplines in order to understand how often people living with HIV move within or outside of the state, and if this mobility is associated with HIV outcomes.
Human Immunodeficiency Virus (HIV) infection remains a significant public health problem in the United States (US). It is estimated that almost 15% of the 1.17 million people living with HIV (PLWH) in the US are unaware of their HIV status. And despite the existence of highly effective HIV treatment (antiretroviral therapy, ART), only 65% of people living with diagnosed HIV have achieved viral suppression. Similarly, among HIV-negative people eligible for PrEP, only 18% have used PrEP.